Item Details

Print View

Competitive Problems in the Pharmaceutical Drug Industry: Hearing Before the Subcommittee on Antitrust, Monopolies [Sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, First Session, on the Generic Drug Industry and Its Concerns With Respect to Competition From the Brand Name Manufacturers, October 21, 1987

United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights
Format
Book; Government Document; Online; EBook
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 1989.
Language
English
Series
S. Hrg. ; 100-922
SuDoc Number
Y 4.J 89/2:S.hrg.100-922
Description
iv, 234 p. : ill., forms ; 24 cm.
Mode of access: Internet.
Notes
  • "Serial no. J-100-40".
  • Includes bibliographical references.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Staff View

    LEADER 02388nam a22004451a 4500
    001 008516651
    003 MiAaHDL
    005 20131017000000.0
    006 m d
    007 cr bn ---auaua
    008 890203s1989 xxu f000 0 eng d
    035
      
      
    a| (MiU)008516651
    035
      
      
    a| sdr-pst.a399317
    035
      
      
    a| sdr-pur1397205
    035
      
      
    a| (OCoLC)19090830
    035
      
      
    a| LIAS533337
    040
      
      
    a| PSt c| PSt d| WaOLN d| MiU
    074
      
      
    a| 1042-A, 1042-B (microfiche)
    086
    0
      
    a| Y 4.J 89/2:S.hrg.100-922
    088
      
      
    a| Serial no. J-100-40 (United States. Congress. Senate. Committee on the Judiciary)
    110
    1
      
    a| United States. b| Congress. b| Senate. b| Committee on the Judiciary. b| Subcommittee on Antitrust, Monopoly, and Business Rights.
    245
    1
    0
    a| Competitive problems in the pharmaceutical drug industry : b| hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987.
    260
      
      
    a| Washington : b| U.S. G.P.O. : b| For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., c| 1989.
    300
      
      
    a| iv, 234 p. : b| ill., forms ; c| 24 cm.
    490
    0
      
    a| S. hrg. ; 100-922
    500
      
      
    a| "Serial no. J-100-40".
    504
      
      
    a| Includes bibliographical references.
    538
      
      
    a| Mode of access: Internet.
    650
      
    0
    a| Pharmaceutical industry z| United States.
    650
      
    0
    a| Generic drugs z| United States.
    650
      
    0
    a| Monopolistic competition z| United States.
    974
      
      
    b| PST c| PST d| 20141114 s| google u| pst.000014994845 z| 4.J 89/2:S.hrg.100-922 y| 1989 r| pd
    974
      
      
    b| PUR c| PUR d| 20140924 s| google u| pur1.32754076878101 y| 1989 r| pd
▾See more
▴See less

Access online

Google Preview

Google Books Preview